231 related articles for article (PubMed ID: 18612538)
1. Salsolinol, an endogenous neurotoxin, enhances platelet aggregation and thrombus formation.
Bae ON; Kim YD; Lim KM; Noh JY; Chung SM; Kim K; Hong S; Shin S; Yoon JH; Chung JH
Thromb Haemost; 2008 Jul; 100(1):52-9. PubMed ID: 18612538
[TBL] [Abstract][Full Text] [Related]
2. Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity.
Jun EA; Lim KM; Kim K; Bae ON; Noh JY; Chung KH; Chung JH
Nanotoxicology; 2011 Jun; 5(2):157-67. PubMed ID: 20822370
[TBL] [Abstract][Full Text] [Related]
3. Platelets possess and require an active protein palmitoylation pathway for agonist-mediated activation and in vivo thrombus formation.
Sim DS; Dilks JR; Flaumenhaft R
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1478-85. PubMed ID: 17303775
[TBL] [Abstract][Full Text] [Related]
4. Genetic strain differences in platelet aggregation and thrombus formation of laboratory rats.
Sudo T; Ito H; Hayashi H; Nagamura Y; Toga K; Yamada Y
Thromb Haemost; 2007 Apr; 97(4):665-72. PubMed ID: 17393031
[TBL] [Abstract][Full Text] [Related]
5. Sulfatides activate platelets through P-selectin and enhance platelet and platelet-leukocyte aggregation.
Merten M; Beythien C; Gutensohn K; Kühnl P; Meinertz T; Thiagarajan P
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):258-63. PubMed ID: 15528476
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of platelet aggregation and thrombus formation by arsenic in drinking water: a contributing factor to cardiovascular disease.
Lee MY; Bae ON; Chung SM; Kang KT; Lee JY; Chung JH
Toxicol Appl Pharmacol; 2002 Mar; 179(2):83-8. PubMed ID: 11884240
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin-induced platelet procoagulant activities: an important clue for chemotherapy-associated thrombosis.
Kim SH; Lim KM; Noh JY; Kim K; Kang S; Chang YK; Shin S; Chung JH
Toxicol Sci; 2011 Nov; 124(1):215-24. PubMed ID: 21865289
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin acts as an endogenous antithrombotic factor.
Kato H; Kashiwagi H; Shiraga M; Tadokoro S; Kamae T; Ujiie H; Honda S; Miyata S; Ijiri Y; Yamamoto J; Maeda N; Funahashi T; Kurata Y; Shimomura I; Tomiyama Y; Kanakura Y
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):224-30. PubMed ID: 16269667
[TBL] [Abstract][Full Text] [Related]
9. [Effects of 3-n-butylphthalide on thrombosis formation and platelet function in rats].
Xu HL; Feng YP
Yao Xue Xue Bao; 2001 May; 36(5):329-33. PubMed ID: 12584852
[TBL] [Abstract][Full Text] [Related]
10. Platelet P-selectin plays an important role in arterial thrombogenesis by forming large stable platelet-leukocyte aggregates.
Yokoyama S; Ikeda H; Haramaki N; Yasukawa H; Murohara T; Imaizumi T
J Am Coll Cardiol; 2005 Apr; 45(8):1280-6. PubMed ID: 15837262
[TBL] [Abstract][Full Text] [Related]
11. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
Béres BJ; Tóth-Zsámboki E; Vargová K; László A; Masszi T; Kerecsen G; Préda I; Kiss RG
Thromb Haemost; 2008 Nov; 100(5):829-38. PubMed ID: 18989527
[TBL] [Abstract][Full Text] [Related]
12. New peptide pENW (pGlu-Asn-Trp) inhibits platelet activation by attenuating Akt phosphorylation.
Xiong J; Bai L; Fang W; Fu J; Fang W; Cen J; Kong Y; Li Y
Eur J Pharm Sci; 2012 Apr; 45(5):552-8. PubMed ID: 22285483
[TBL] [Abstract][Full Text] [Related]
13. [Effect of phenolic alkaloids of Menispermum dauricum on thrombosis and platelet aggregation].
Kong XY; Gong PL
Yao Xue Xue Bao; 2005 Oct; 40(10):916-9. PubMed ID: 16408809
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of lycopene on in vitro platelet activation and in vivo prevention of thrombus formation.
Hsiao G; Wang Y; Tzu NH; Fong TH; Shen MY; Lin KH; Chou DS; Sheu JR
J Lab Clin Med; 2005 Oct; 146(4):216-26. PubMed ID: 16194683
[TBL] [Abstract][Full Text] [Related]
15. Quantification of platelet composition in experimental venous thrombosis by real-time polymerase chain reaction.
Wang X; Hsu MY; Steinbacher TE; Monticello TM; Schumacher WA
Thromb Res; 2007; 119(5):593-600. PubMed ID: 16797058
[TBL] [Abstract][Full Text] [Related]
16. Bromelain proteases reduce human platelet aggregation in vitro, adhesion to bovine endothelial cells and thrombus formation in rat vessels in vivo.
Metzig C; Grabowska E; Eckert K; Rehse K; Maurer HR
In Vivo; 1999; 13(1):7-12. PubMed ID: 10218125
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of platelet aggregation by 1-methyl-4-phenyl pyridinium ion (MPP+) through ATP depletion: Evidence for the reduced platelet activities in Parkinson's disease.
Lim KM; Kim HH; Bae ON; Noh JY; Kim KY; Kim SH; Chung SM; Shin S; Kim HY; Chung JH
Platelets; 2009 May; 20(3):163-70. PubMed ID: 19437333
[TBL] [Abstract][Full Text] [Related]
18. Hypotensive and antiaggregative effects of eugenosedin-B with serotonin and alpha/beta-adrenoceptor antagonistic activities in rats and human platelets.
Shen KP; Chu LW; Hsieh SL; An LM; Chen IJ; Wu BN
J Cardiovasc Pharmacol; 2008 Feb; 51(2):154-61. PubMed ID: 18287883
[TBL] [Abstract][Full Text] [Related]
19. Arsenite-enhanced procoagulant activity through phosphatidylserine exposure in platelets.
Bae ON; Lim KM; Noh JY; Chung SM; Kim H; Lee CR; Park JD; Chung JH
Chem Res Toxicol; 2007 Dec; 20(12):1760-8. PubMed ID: 17915961
[TBL] [Abstract][Full Text] [Related]
20. Serotonergic mechanisms enhance platelet-mediated thrombogenicity.
Galan AM; Lopez-Vilchez I; Diaz-Ricart M; Navalon F; Gomez E; Gasto C; Escolar G
Thromb Haemost; 2009 Sep; 102(3):511-9. PubMed ID: 19718472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
